Jeff Yass’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-15,800
Closed -$65.3K – 14349
2026
Q2
$65.3K Buy
+15,800
New +$68.2K ﹤0.01% 12728
2023
Q4
– Sell
-17,600
Closed -$257K – 13139
2023
Q3
$257K Buy
17,600
+5,000
+40% +$84.6K ﹤0.01% 9687
2023
Q2
$214K Buy
+12,600
New +$185K ﹤0.01% 10142
2022
Q2
– Sell
-29,000
Closed -$246K – 13751
2022
Q1
$246K Buy
+29,000
New +$267K ﹤0.01% 10749
2021
Q4
– Sell
-88,700
Closed -$1.57M – 13758
2021
Q3
$1.57M Buy
+88,700
New +$1.67M ﹤0.01% 6359
2021
Q2
– Sell
-34,600
Closed -$686K – 13138
2021
Q1
$686K Buy
34,600
+12,500
+57% +$291K ﹤0.01% 8720
2020
Q4
$411K Buy
22,100
+5,400
+32% +$118K ﹤0.01% 8681
2020
Q3
$420K Sell
16,700
-3,600
-18% -$89.7K ﹤0.01% 8032
2020
Q2
$620K Buy
+20,300
New +$621K ﹤0.01% 6909

Other funds holding RCEL

Jeff Yass's RCEL Position: Q3 2026 in Review

Jeff Yass opened a new position in Avita Medical (RCEL) in Q3 2026: 242,311 shares worth $2.84M. The stake represents ﹤0.01% of the portfolio and ranks #5525 among its holdings. This is a return to the name: Jeff Yass previously reported a position in RCEL as recently as Q3 2025.

Jeff Yass first reported a position in RCEL in Q2 2020 and has held it in 21 quarters since. The position peaked at $3.21M in Q1 2023. 89 funds tracked by Wall St. Rank hold RCEL as of Q3 2026.

  • Jeff Yass held 242,311 shares of Avita Medical worth $2.84M as of Q3 2026.
  • Avita Medical was a new Jeff Yass position in Q3 2026.
  • Avita Medical made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #5525 holding.
  • Jeff Yass first reported a position in Avita Medical in Q2 2020 and has held it in 21 quarters since.
  • Jeff Yass's Avita Medical position peaked at $3.21M in Q1 2023.
  • 89 funds tracked by Wall St. Rank held Avita Medical as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.